Apellis Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated as of November 16, 2018, by and between the Registrant and Adam Townsend
Apellis Pharmaceuticals, Inc.
Biotechnology
2022
Offer Letter, dated as of April 20, 2020, by and between the Registrant and Nur Nicholson
Apellis Pharmaceuticals, Inc.
Biotechnology
2022
Description of Securities Registered Under Section 12 of the Exchange Act
Apellis Pharmaceuticals, Inc.
Biotechnology
2022
Open Market Sale AgreementSM, dated as of January 20, 2022, by and between Apellis Pharmaceuticals, Inc. and Jefferies LLC
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2022
Description of Securities Registered Under Section 12 of the Exchange Act
Apellis Pharmaceuticals, Inc.
Biotechnology
2021
Form of Capped Call Transaction Confirmation
Apellis Pharmaceuticals, Inc.
Biotechnology
2020
Description of Securities Registered Under Section 12 of the Exchange Act
Apellis Pharmaceuticals, Inc.
Biotechnology
2020
Form of Capped Call Transaction Confirmation
Apellis Pharmaceuticals, Inc.
Biotechnology
2019
Offer Letter, dated as of April 13, 2018, by and between the Registrant and Lukas Scheibler
Apellis Pharmaceuticals, Inc.
Biotechnology
MA
2019
Offer Letter, dated as of October 9, 2017, by and between the Registrant and Timothy Sullivan
Apellis Pharmaceuticals, Inc.
Biotechnology
MA
2017
Offer Letter, dated as of March 7, 2017, by and between the Registrant and Steven Axon
Apellis Pharmaceuticals, Inc.
Biotechnology
2017
VOTINGAGREEMENT
Apellis Pharmaceuticals, Inc.
Biotechnology
2015